What Core Scientific, Inc./tx's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 3 | 4 |
| Sells | 15 | 53 |
| Total trades | 23 | 91 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 49,000 | 1,627,396 |
| Disposed | 179,957 | 1,999,485 |
| Net activity | −130,957 | −372,089 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Rozov Yadin | Director | Nov 11 | In/At-money Exercise · X | +30,000 | $6.81 | +$204K | 484,162 |
| Duchene Todd M | See remarks | Nov 09 | Disclosed 10b5-1 sale · S | −2,100 | $12.70 | −$26.7K | 1,113,286 |
| Duchene Todd M | See remarks | Nov 09 | Disclosed 10b5-1 sale · S | −7,900 | $12.39 | −$97.9K | 1,115,386 |
| Duchene Todd M | See remarks | Nov 02 | Disclosed 10b5-1 sale · S | −100 | $13.37 | −$1.34K | 1,123,286 |
| Duchene Todd M | See remarks | Nov 02 | Disclosed 10b5-1 sale · S | −9,900 | $12.78 | −$126K | 1,123,386 |
| Duchene Todd M | See remarks | Oct 26 | Disclosed 10b5-1 sale · S | −5,500 | $13.80 | −$75.9K | 1,133,286 |
| Duchene Todd M | See remarks | Oct 26 | Disclosed 10b5-1 sale · S | −4,500 | $13.27 | −$59.7K | 1,138,786 |
| Duchene Todd M | See remarks | Oct 19 | Disclosed 10b5-1 sale · S | −10,000 | $13.87 | −$139K | 1,143,286 |
| Duchene Todd M | See remarks | Oct 16 | Withheld — tax / exercise cost · F | −6,382 | $14.46 | −$92.3K | 1,153,286 |
| Sullivan Adam Taylor | Chief Executive Officer | Oct 16 | Withheld — tax / exercise cost · F | −21,839 | $14.46 | −$316K | 4,391,079 |
| Duchene Todd M | See remarks | Oct 12 | Disclosed 10b5-1 sale · S | −10,000 | $15.12 | −$151K | 1,159,668 |
| Duchene Todd M | See remarks | Oct 05 | Disclosed 10b5-1 sale · S | −10,000 | $16.31 | −$163K | 1,169,668 |
| Sullivan Adam Taylor | Chief Executive Officer | Oct 01 | Withheld — tax / exercise cost · F | −23,508 | $15.98 | −$376K | 4,412,918 |
| Duchene Todd M | See remarks | Oct 01 | Withheld — tax / exercise cost · F | −8,228 | $15.98 | −$131K | 1,179,668 |
| Duchene Todd M | See remarks | Sep 28 | Disclosed 10b5-1 sale · S | −10,000 | $16.76 | −$168K | 1,187,896 |
| Duchene Todd M | See remarks | Sep 21 | Disclosed 10b5-1 sale · S | −10,000 | $18.37 | −$184K | 1,197,896 |
| Weiss Eric Stanton | Director | Sep 15 | Open-market buy · P | +6,000 | $16.33 | +$98K | 265,262 |
| Duchene Todd M | See remarks | Sep 14 | Disclosed 10b5-1 sale · S | −10,000 | $17.14 | −$171K | 1,207,896 |
| Duchene Todd M | See remarks | Sep 08 | Disclosed 10b5-1 sale · S | −10,000 | $18.67 | −$187K | 1,217,896 |
| Duchene Todd M | See remarks | Aug 31 | Disclosed 10b5-1 sale · S | −10,000 | $16.23 | −$162K | 1,927,896 |
Loading...